Curcumin Bioavailability in Glioblastoma Patients

Completed

• Conditions: Patient Harboring Glioblastoma That Will Undergo Surgery

• Registration Number: NCT01712542
• Lead Sponsor: Johann Wolfgang Goethe University Hospital

Brief Summary

Measuring the bioavailability of orally administered curcumin in the tumors of glioblastoma patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10
• Study First Submitted: 2012-10-20
• Study First Submitted QC: 2012-10-22
• Study First Posted: 2012-10-23
• Primary Completion: 2013-05
• Study Completion: 2013-05
• Status Verified: 2013-06
• Last Update Submitted: 2013-06-01
• Last Update Posted: 2013-06-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Patients harboring Glioblastoma
• Patient will undergo surgery

Exclusion Criteria

• BMI > 30
• Liver and Kidney Function so compromised that medication is prescribed

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Concentration of Curcumin in Glioblastoma	At Tumor resection	At the time of surgery

Trial Locations

Locations (1)

Department of Neurosurgery, Johann Wolfgang Goethe-University; 🇩🇪 Frankfurt, Hessen, Germany